Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis (AKTSS)

NCT03296345 is registered in ClinicalTrials.gov with UCSF Benioff Children's Hospital Oakland as lead sponsor.

NCT NCT03296345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03296345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis (AKTSS)
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2016
Completion date
April 30, 2018
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, vaso-occlusive crisis